New NUS spin-off company to reduce cancer death and disease burden through real time cancer diagnosi

Issuing time:2014-11-22 00:00

Endofotonics Pte Ltd, an NUS spin-off company, issued a joint press release with NUS to announce its launch. Endofotonics’ launch generated coverage in more than 260 media including Reuters, Yahoo Finance and The Business Journal.

PrevMedical Physics Web: Nov 13, 2014: Raman device diagnoses from inside the body

NextCambridge Network 4/11/2014: Cambridge Consultants develops a world first in diagnostics

Article classification: EVENTS

Share to：

| | | |

Singapore Main Office

67 Ayer Rajah Crescent, #03-01/02

LaunchPad @ onenorth, Singapore 139950

China, Shanghai Office

R51, 14th Floor, 800 Shangcheng Road,

Pudong District, Shanghai

For any enquiries, please write to contact@endofotonics.com and we will get back to you as soon as possible.

Disclaimer: Endofotonics products shown in this website may not be registered, approved for sale, or available for purchase in all countries where the website is accessible. Please consult your local Endofotonics representative for more information. Prior to undergoing esophago-gastro-duodenoscopy (EGD) procedures, please consult your healthcare professional to provide you with the possible risk and benefits associated with SPECTRA IMDx™ System.

HOME TEAM PRODUCT PUBLICATIONS CONTACT